2019 Asembia Specialty Pharmacy Summit

April 29 - May 2, 2019 | Las Vegas, NV

At AmerisourceBergen, we connect all points of the healthcare spectrum, driving access to pharmaceutical care and helping manufacturers and providers navigate the complexities of the healthcare delivery ecosystem. Let’s connect at the Asembia Specialty Pharmacy Summit. Visit us in booth #311 to learn how we can partner to remove barriers to better care and change lives together.

Panel Discussion

                                                                                                                                                                                                                         

Data Rules! Strategies for Leveraging Data and Defining Value Based Care

TUESDAY, APRIL 30, 1:45PM - 2:15PM | ROOM: MOUTON 

As specialty drugs dominate the market, payers and manufacturers develop networks of specialty pharmacies to manage cost and obtain data. Basic reporting is not enough, and value must be defined. Health system specialty pharmacies are uniquely positioned to provide coordinated care, utilizing robust data from multiple sites of care and a patient-centric model. This panel explores data needs from various stakeholders and how this impacts product uptake, access and patient outcomes.

Moderator: Kristin Chambers, Vice President, Strategic Development, AmerisourceBergen Panelists: Diane Giaquinta, President, StrategiCare; Elizabeth Forner, Director of National Oncology Pathway Strategy, Eisai; Tom Koenig, Executive Director Biosimilar Market Access, Boehringer Ingelheim; Champ Burgess, VP Pharmacy Ventures, University Hospitals Health System

Kristin Chambers AmerisourceBergen

Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies

As specialty therapies become a bigger part of the pharmaceutical landscape, more and more health systems are entering the specialty pharmacy space. Health system specialty pharmacies (HSSPs) provide the required high-touch, specialized support to minimize adverse events, mitigate financial barriers and improve therapy compliance and adherence for patients taking these specialty medications. But the HSSP's value extends beyond the financial benefits it provides to the health system. 
Download the white paper

Featured News